Document is current
Any future updates will be listed below
-
Authors
Jiang, Xiaoke
Luo, Xiaoying
Cai, Conghui
Bai, Yangqiu
Ding, Hui
Yue, Han
Li, Yalong
Yang, Zhiyu
Zhang, Huimin
Liang, Yuan
Peng, Cong
Huang, Huanrong
Liu, Min
Li, Zhenjuan
Shi, Yujie
Han, Shuangyin
Li, Xiuling
Zhang, Bingyong https://orcid.org/0000-0003-3515-9954
-
Funding
Funding for this research was provided by:
medical science and technology project of Henan Province (SBGJ202001002)
National Health Commission project (CMR-20180615-1001)
Science and Technology Department of Henan Province (212102310203)
- License Information
-
More Information
Article History
Received: 12 April 2024
Accepted: 1 August 2024
First Online: 2 September 2024
Declarations
:
: The study was authorized by the Ethics Committee of Henan Provincial People’s Hospital (project title: Clinical study of mesenchymal stem cells in the treatment of moderately refractory ulcerative colitis; Approval number: (2018) NO.03 − 01; date of approval: 25 January 2018). All patients provided written informed consent.
: Not applicable.
: All authors declare there are no conflicts of interest.
